77
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Copolymers of acrylic acid with 2-hydroxyethyl methacrylate as carriers of two tuberculostatics: Synthesis, properties in solutions, drug release

, &
Pages 480-488 | Received 06 Apr 2022, Accepted 06 Jun 2022, Published online: 16 Jun 2022
 

Abstract

Polymeric carrier for combination therapy of tuberculosis, namely low molecular weight reactive copolymer of acrylic acid with 2-hydroxyethyl methacrylate (AA-co-2-HEMA) with two types of functional groups along the chain has been synthesized. Characteristic features of radical copolymerization were studied and the relationships between the synthesis conditions and the composition, microstructure, and molecular characteristics of the copolymers were established, that is of fundamental interest. The behavior of copolymer macromolecules in aqueous salt solutions was analyzed. A tuberculostatically active derivative of AA-co-2-HEMA containing the amikacin antibiotic and the monofluoroquinolone ciprofloxacin was synthesized. The target multiunit copolymer containing two tuberculostatics with different effect against tuberculosis mycobacterium exhibits high anti-tuberculosis activity. It is characterized by a gradual release of the drugs from the polymer form and is very promising for use in combination therapy of tuberculosis.

GRAPHICAL ABSTRACT

Acknowledgements

The authors are grateful to Prof. Dr. V. V. Tets for conducting microbiological studies of ciprofloxacin, amikacin and their polymeric derivatives and Dr. A. I. Amirova for help in hydrodynamic measurements.

Disclosure statement

The authors report there are no competing interests to declare.

Data availability statement

The data that support the findings of this study are available from the corresponding author, E.T., upon reasonable request.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.